Inogen | INGN - Interest Expense On Debt


Inogen reported 1.03M in Interest Expense on Debt for its fiscal quarter ending in March of 2025.





Interest Expense On Debt Change Date
Abbott USD 297M 2M Sep/2026
Accuray USD 2.88M 72K Dec/2024
AngioDynamics USD 102K 2K Sep/2025
Artivion USD 5.53M 589K Dec/2025
AtriCure USD 1.2M 15K Jun/2026
Baxter International USD 64M 14M Jun/2026
Becton, Dickinson and Co. USD 130M 2M Sep/2026
Boston Scientific USD 100M 4M Sep/2026
Cooper Companies USD 21.5M 600K Jun/2026
Dexcom USD 3.1M 100K Sep/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
Globus Medical USD 5.53B 39.93M Sep/2026
Inogen 1.03M 384K Mar/2025
Insulet USD 12.3M 1.3M Sep/2026
Medtronic USD 186M 10M Jun/2026
Orthofix International 4.68M 731K Sep/2025
Philips EUR 84M 1000K Sep/2026
ResMed USD 8.79M 14.55M Sep/2025
Steris USD 11.2M 4.6M Sep/2026
Stryker USD 47.25B 683M Sep/2026
Tandem Diabetes Care USD 1.16B 5.29M Sep/2026
Teleflex USD 21.21M 6.75M Sep/2026
Zimmer Biomet Holdings USD 23.54B 740.8M Sep/2026